Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 29, 2013
Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients
Tamer A Ahmed, John Hayslip, Markos Leggas
Leukemia Research
|
September 29, 2014
Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition
Tamer A Ahmed, John Hayslip, Markos Leggas
Journal of Pharmaceutical Analysis
|
February 7, 2018
Validated LC-MS/MS method for simultaneous determination of SIM and its acid form in human plasma and cell lysate: Pharmacokinetic application
Tamer A Ahmed, Jamie Horn, John Hayslip, et al.
Journal of Natural Products
|
July 5, 2012
Saquayamycins G-K, cytotoxic angucyclines from Streptomyces sp. Including two analogues bearing the aminosugar rednose
Khaled A Shaaban, Tamer A Ahmed, Markos Leggas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 16, 2005
Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes
Margaret L Shumate, Gladys Yumet, Tamer A Ahmed, et al.
The Journal of Antibiotics
|
October 11, 2012
Pyramidamycins A-D and 3-hydroxyquinoline-2-carboxamide; cytotoxic benzamides from Streptomyces sp. DGC1
Khaled A Shaaban, Micah D Shepherd, Tamer A Ahmed, et al.
Cell Reports
|
January 4, 2019
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors
Tamer A Ahmed, Christos Adamopoulos, Zoi Karoulia, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
March 31, 2007
Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes
Tamer A Ahmed, Mark D Buzzelli, Charles H Lang, et al.
Cancer Cell
|
August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling
Zoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Nature Cancer
|
September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
Xuewei Wu, Xiaobao Yang, Yan Xiong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cancer Chemotherapy and Pharmacology
|
October 29, 2013
Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients
Tamer A Ahmed, John Hayslip, Markos Leggas
Leukemia Research
|
September 29, 2014
Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition
Tamer A Ahmed, John Hayslip, Markos Leggas
Journal of Pharmaceutical Analysis
|
February 7, 2018
Validated LC-MS/MS method for simultaneous determination of SIM and its acid form in human plasma and cell lysate: Pharmacokinetic application
Tamer A Ahmed, Jamie Horn, John Hayslip, et al.
Journal of Natural Products
|
July 5, 2012
Saquayamycins G-K, cytotoxic angucyclines from Streptomyces sp. Including two analogues bearing the aminosugar rednose
Khaled A Shaaban, Tamer A Ahmed, Markos Leggas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 16, 2005
Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes
Margaret L Shumate, Gladys Yumet, Tamer A Ahmed, et al.
The Journal of Antibiotics
|
October 11, 2012
Pyramidamycins A-D and 3-hydroxyquinoline-2-carboxamide; cytotoxic benzamides from Streptomyces sp. DGC1
Khaled A Shaaban, Micah D Shepherd, Tamer A Ahmed, et al.
Cell Reports
|
January 4, 2019
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors
Tamer A Ahmed, Christos Adamopoulos, Zoi Karoulia, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
March 31, 2007
Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes
Tamer A Ahmed, Mark D Buzzelli, Charles H Lang, et al.
Cancer Cell
|
August 16, 2016
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling
Zoi Karoulia, Yang Wu, Tamer A Ahmed, et al.
Nature Cancer
|
September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
Xuewei Wu, Xiaobao Yang, Yan Xiong, et al.
Page
of 2